On Thursday, the FDA approved Elanco Animal Health Incorporated’s (NYSE:ELAN) Zenrelia, a once-daily oral JAK inhibitor for the control of pruritus (itching) associated with allergic dermatitis and ...
Hunter, Trooper, Scrappy and Buckaroo find zen by using Zenrelia Newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, compares clinical outcomes between ...
(RTTNews) - Elanco Animal Health Incorporated (ELAN) on Tuesday said that the U.S. Food and Drug Administration (FDA) has approved an updated label for its Zenrelia, removing language related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results